What does Dr. Kjell Van Royen do?

Dr. Kjell Van Royen is a specialist medical practice in Asse. Private Limited, started on 22 December 2020, 1 establishment.

What is the address of Dr. Kjell Van Royen?

The registered office of Dr. Kjell Van Royen is located at Winkelbaan 36, 1730 Asse.

Is Dr. Kjell Van Royen still active?

Yes. According to the CBE (16 September 2026) Dr. Kjell Van Royen is active, legal situation “Normale toestand”, started on 22 December 2020.

Is Dr. Kjell Van Royen registered on Peppol?

Yes, Dr. Kjell Van Royen is registered on the Peppol network with ID 0208:0760428629.

What is the enterprise number of Dr. Kjell Van Royen?

The enterprise number of Dr. Kjell Van Royen is BE0760428629.

When was Dr. Kjell Van Royen founded?

Dr. Kjell Van Royen was founded on 22 December 2020.

Who are the directors of Dr. Kjell Van Royen?

According to the 2025 annual accounts, the directors of Dr. Kjell Van Royen are: Kjell Van Royen.

Is Dr. Kjell Van Royen a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 22 December 2020; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Kjell Van Royen make in 2025?

Dr. Kjell Van Royen posted a profit after taxes of € 247,261 in financial year 2025.

What is the revenue of Dr. Kjell Van Royen?

As a small company, Dr. Kjell Van Royen is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 338,069.

Dr. Kjell Van Royen (Private Limited) - Asse

Dossier Dr. Kjell Van Royen, printed on 16 September 2026 from databakkes.be/en/0760428629/dr-kjell-van-royen. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Kjell Van Royen from Asse, company number BE0760428629, closed financial year 2025 with a result of € 247,261 after tax. For that financial year Dr. Kjell Van Royen recorded a gross margin of € 338,069 and equity of € 3,000. Compared with financial year 2024, the result moved from € 240,015 to € 247,261. Profitable, and profit is growing. The buffer shrank hard: equity is 99 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on March 6, 2026.

What it is worth Shrank hard

€ 3,000

▼ 99% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 247,261

▲ 3% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 196,482

▲ 40% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 487,276 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 20,312

▼ 28% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 1 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 18,231

▼ 39% vs 2024

€ 12,878 is repaid this year. At this pace the long-term loan is gone in ≈ 1 years.

Taxes

€ 5,849

▲ 209% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 175,099 Gross margin 2022: € 175,099 First fiscal year in the series	€ 300,931 Gross margin 2023: € 300,931 ▲ 72% vs 2022 (€ 175,099) Favourable step	€ 328,492 Gross margin 2024: € 328,492 ▲ 9% vs 2023 (€ 300,931) Favourable step	€ 338,069 Gross margin 2025: € 338,069 ▲ 3% vs 2024 (€ 328,492) Favourable step	▲ 3%
Profit after taxes	€ 127,287 Profit after taxes 2022: € 127,287 First fiscal year in the series	€ 217,224 Profit after taxes 2023: € 217,224 ▲ 71% vs 2022 (€ 127,287) Favourable step	€ 240,015 Profit after taxes 2024: € 240,015 ▲ 10% vs 2023 (€ 217,224) Favourable step	€ 247,261 Profit after taxes 2025: € 247,261 ▲ 3% vs 2024 (€ 240,015) Favourable step	▲ 3%
Equity	€ 179,205 Equity 2022: € 179,205 First fiscal year in the series	€ 220,224 Equity 2023: € 220,224 ▲ 23% vs 2022 (€ 179,205) Favourable step	€ 243,015 Equity 2024: € 243,015 ▲ 10% vs 2023 (€ 220,224) Favourable step	€ 3,000 Equity 2025: € 3,000 ▼ 99% vs 2024 (€ 243,015) Unfavourable step	▼ 99%
Total debts	€ 82,730 Total debts 2022: € 82,730 First fiscal year in the series	€ 63,406 Total debts 2023: € 63,406 ▼ 23% vs 2022 (€ 82,730) Favourable step	€ 40,166 Total debts 2024: € 40,166 ▼ 37% vs 2023 (€ 63,406) Favourable step	€ 279,056 Total debts 2025: € 279,056 ▲ € 238,890 vs 2024 (€ 40,166) Unfavourable step	▲ € 238,890
Cash	€ 99,727 Cash 2022: € 99,727 First fiscal year in the series	€ 130,060 Cash 2023: € 130,060 ▲ 30% vs 2022 (€ 99,727) Favourable step	€ 140,100 Cash 2024: € 140,100 ▲ 8% vs 2023 (€ 130,060) Favourable step	€ 196,482 Cash 2025: € 196,482 ▲ 40% vs 2024 (€ 140,100) Favourable step	▲ 40%
Retained profit	€ 176,205 Retained profit 2022: € 176,205 First fiscal year in the series	€ 217,224 Retained profit 2023: € 217,224 ▲ 23% vs 2022 (€ 176,205) Favourable step	€ 240,015 Retained profit 2024: € 240,015 ▲ 10% vs 2023 (€ 217,224) Favourable step	€ 0 Retained profit 2025: € 0 ▼ 100% vs 2024 (€ 240,015) Unfavourable step	▼ 100%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 176,205 Dividend 2023: € 176,205 Unchanged (€ 0) Unchanged	€ 217,224 Dividend 2024: € 217,224 ▲ 23% vs 2023 (€ 176,205) Unchanged	€ 487,276 Dividend 2025: € 487,276 ▲ 124% vs 2024 (€ 217,224) Unchanged	▲ 124%
Bank debt	€ 54,713 Bank debt 2022: € 54,713 First fiscal year in the series	€ 42,399 Bank debt 2023: € 42,399 ▼ 23% vs 2022 (€ 54,713) Favourable step	€ 29,901 Bank debt 2024: € 29,901 ▼ 29% vs 2023 (€ 42,399) Favourable step	€ 18,231 Bank debt 2025: € 18,231 ▼ 39% vs 2024 (€ 29,901) Favourable step	▼ 39%
Balance sheet total	€ 261,935 Balance sheet total 2022: € 261,935 First fiscal year in the series	€ 283,630 Balance sheet total 2023: € 283,630 ▲ 8% vs 2022 (€ 261,935) Unchanged	€ 283,181 Balance sheet total 2024: € 283,181 Unchanged (€ 283,630) Unchanged	€ 282,056 Balance sheet total 2025: € 282,056 Unchanged (€ 283,181) Unchanged

Key figures of Dr. Kjell Van Royen, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Kjell Van Royen?

What happened at Dr. Kjell Van Royen in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Mar 6, 2026 New annual accounts for financial year 2025: profit of € 247,261 (▲ 3% vs 2024). Source: NBB ↗
Dec 22, 2020 New establishment in Asse. KBO
Dec 22, 2020 Start of the company according to the CBE. KBO

In short

From € 127,287 profit in 2022 to € 247,261 profit in 2025.

Paid € 255,904 in corporate taxes since 2022.

Best year ever: 2025, with € 247,261 profit.

Paid out € 880,705 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Kjell Van Royen? We notify you, reason included.

Follow Dr. Kjell Van Royen

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Kjell Van Royen

Dr. Kjell Van Royen

Orthopedie-traumatologie AZORG 4.8%

Behind Dr. Kjell Van Royen is Kjell Van Royen. It owns 4.8% of Orthopedie-traumatologie AZORG itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Kjell Van Royen

Andere functie

Establishments

Establishment units

Physical locations of this company

Registered office

Winkelbaan 36

1730 Asse

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

Dr. Barbara Chomé

€ 80,765 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0760.428.629

VAT number

BE 0760.428.629

Registered office

Winkelbaan 36, 1730 Asse

Names & denominations

Dr. Kjell Van Royen

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

22 December 2020

Peppol

Active · Active since 5 Nov 2025

Contact

[email protected]

Activities · NACE

Activiteiten van medisch specialisten

Overige zakelijke dienstverlening, neg

View on CBE Public ↗ Annual accounts (NBB) ↗

Dr. Kjell Van Royen

Financials

What happened to Dr. Kjell Van Royen?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions